Glaxo Paid Doctors $15 Million Before Promised End to Fees
This article is for subscribers only.
GlaxoSmithKline Plc paid U.S. doctors about $15 million in 2014 to promote and learn about its products, showing little change from the previous year even as it works to end most payments to physicians by 2016.
The total includes consulting and speaking fees, as well as meals and travel for thousands of doctors. The largest consulting payment -- $195,000 -- went to Joseph Goldstein, a professor of biomedical research at the University of Texas Southwestern Medical Center, according to Glaxo’s figures.